Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 300 | Published : January 2022 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.

The main types of ophthalmology drugs are antiglaucoma drugs, dry eye medication, and other ophthalmological drugs (retinal disorders, anti-infectives/allergy). Anti-glaucoma drugs are medications used to prevent or treat glaucoma, which is a disease in which the optic nerve is damaged, resulting in progressive, irreversible vision loss. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global ophthalmology drugs market size is expected to grow from $50.62 billion in 2021 to $56.07 billion in 2022 at a compound annual growth rate (CAGR) of 10.8%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The ophthalmology drugs market is expected to reach $127.15 billion in 2026 at a CAGR of 22.7%.

The expected rise in eye laser surgeries will contribute to the ophthalmology drugs market. Ophthalmology research has proved a link between laser eye surgeries and the prevalence of dry eye disorders. In an eye laser procedure, cutting of some nerves in the cornea leads to reduction in corneal sensitivity, in response to which, eyes may not sense the need for lubrication, causing the body to produce fewer tears. Dry eye is a common side effect after laser vision correction surgeries. It is estimated that almost half of the patients that undergo a laser surgery experience some degree of dry eye condition following the procedure. The number of eye laser procedures rose to 720,000 a year in 2020. A rising number of people going for laser eye surgeries is expected to increase the demand for dry eye medications in the forecast period driving the ophthalmology drugs market.

Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to data protection such as the European Union's General Data Protection Regulation (GDPR), changes to drug approval procedures and other regulatory changes. For instance, according to a study on 100 Data Privacy and Data Security statistics for 2020, GDPR compliance is a top priority for 58% of European companies. The GDPR regulation is a EU law on data protection and privacy of individuals residing the European Union and the European Economic Area (EEA). It also regulates data anonymization thus maintaining integrity of data dealing with patients and other clinical trial studies. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts strain to investments relating to new product development, thereby affecting the growth of the ophthalmology drugs market.

Drug manufacturers are increasingly developing ophthalmic drugs with anti-inflammatory agents to ease patient treatment for dry eye syndrome. Anti-inflammatory drugs are widely used for the treatment of the inflammation produced by the dry eye syndrome, with the topical corticosteroid drops being the most common therapy. Corticosteroids can rapidly and effectively relieve the symptoms and signs of moderate or severe dry eye. However, prolonged usage of corticosteroids has seen to produce side effects that include risk of bacterial or fungal infection, elevated intraocular pressure and cataract formation. As a consequence, NSAIDs are increasingly being used as dry eye treatment instead of steroids to minimize the side effects. For instance, Aciex Therapeutics, a US-based pharmaceutical company, is developing NSAIDs which decrease ocular discomfort.

Major companies in the ophthalmology drugs market include Regeneron Pharmaceuticals, Inc., Novartis AG, AbbVie, Santen Pharmaceutical Co., F. Hoffmann-La Roche Ltd., Bausch Health Companies Inc., Bayer AG, Sumitomo Chemical Co ltd, Mitsubishi Tanabe Pharma Corporation and Horizon Therapeutics plc.

North America was the largest region in the ophthalmology drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the ophthalmology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ophthalmology drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global ophthalmology drugs market is segmented -

1) By Type: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

List Of Tables

    Table 1: Global Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 2: Global Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5: Global Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, Split By Region
  • Table 6: Global Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Region
  • Table 7: Global Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8: Global Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11: Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12: Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13: Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 14: Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 15: Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 16: Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 17: Global Ophthalmology Drugs Market Value, Market Size As A Percentage Of Global GDP, 2016 – 2026
  • Table 18: Global Ophthalmology Drugs Market, Per Capita Average Ophthalmology Drugs Market Industry Expenditure, 2016 – 2026, ($)
  • Table 19: Global Ophthalmology Drugs Percentage Of GDP, By Country, 2021, %
  • Table 20: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 21: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 22: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 23:  Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 24: Asia-Pacific, Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 25: Asia-Pacific Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 26: Asia-Pacific Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 27: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 28: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 29: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 30: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 31: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 32: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 33: Asia-Pacific Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
  • Table 34: Asia-Pacific Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, By Country
  • Table 35: Asia-Pacific Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Country
  • Table 36: Asia-Pacific Per Capita Ophthalmology Drugs Expenditure, By Country, 2021, $
  • Table 37: Australia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 38: Australia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 39: Australia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 40: Australia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 41: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 42: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 43: Australia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 44: Australia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 45: Bangladesh Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 46: Bangladesh Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 47: China Population By Age Group, 2016-2026, Thousands
  • Table 48: China GDP Per Capita, 2016-2021, $
  • Table 49:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 50: China Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 51: China Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 52: China Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 53: China Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 54: China Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 55: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 56: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 57: China Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 58: China Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 59: Hong Kong Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 60: Hong Kong Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 61: India Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 62: India Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 63: India Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 64: India Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 65: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 66: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 67: India Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 68: India Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 69: Indonesia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 70: Indonesia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 71: Indonesia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 72: Indonesia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 73: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 74: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 75: Indonesia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 76: Indonesia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 77: Japan Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 78: Japan Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 79: Japan Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 80: Japan Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 81: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 82: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 83: Japan Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 84: Japan Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 85: Malaysia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 86: Malaysia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 87: New Zealand Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 88: New Zealand Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 89: Philippines Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 90: Philippines Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 91: Singapore Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 92: Singapore Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 93: South Korea Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 94: South Korea Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 95: South Korea Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 96: South Korea Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 97: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 98: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 99: South Korea Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 100: South Korea Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 101: Thailand Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 102: Thailand Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 103: Vietnam Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 104: Vietnam Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 105: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 106: Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 107:  Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 108:  Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 109: Western Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 110: Western Europe Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 111: Western Europe Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 112: Western Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 113: Western Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 114: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 115: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 116: Western Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 117: Western Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 118: Western Europe Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
  • Table 119: Western Europe Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, By Country
  • Table 120: Western Europe Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Country
  • Table 121: Western Europe Per Capita Ophthalmology DrugsExpenditure, By Country, 2021, $
  • Table 122: Austria Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 123: Austria Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 124: Belgium Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 125: Belgium Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 126: Denmark Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 127: Denmark Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 128: Finland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 129: Finland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 130: France Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 131: France Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 132: France Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 133: France Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 134: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 135: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 136: France Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 137: France Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 138: Germany Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 139: Germany Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 140: Germany Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 141: Germany Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 142: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 143: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 144: Germany Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 145: Germany Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 146: Ireland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 147: Ireland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 148: Italy Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 149: Italy Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 150: Netherlands Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 151: Netherlands Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 152: Norway Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 153: Norway Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 154: Portugal Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 155: Portugal Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 156: Spain Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 157: Spain Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 158: Sweden Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 159: Sweden Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 160: Switzerland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 161: Switzerland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 162: UK Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 163: UK Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 164: UK Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 165: UK Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 166: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 167: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 168: UK Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 169: UK Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 170: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 171: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 172:  Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 173:  Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 174: Eastern Europe Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 175: Eastern Europe Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 176: Eastern Europe Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 177: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 178: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 179: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 180: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 181: Eastern Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 182: Eastern Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 183: Eastern Europe Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
  • Table 184: Eastern Europe Ophthalmology Drugs Market, 2016 – 2026, Historic And Forecast Growth Rate, By Country
  • Table 185: Eastern Europe Ophthalmology Drugs Market, 2021 – 2026, Growth And Market Share Comparison, By Country
  • Table 186: Eastern Europe Per Capita Ophthalmology Drugs Expenditure, By Country, 2021, $
  • Table 187: Czech Republic Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 188: Czech Republic Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 189: Poland Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 190: Poland Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 191: Romania Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 192: Romania Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 193: Russia Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 194: Russia Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 195: Russia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 196: Russia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 197: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 198: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 199: Russia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 200: Russia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 201: Ukraine Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 202: Ukraine Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 203: North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 204: North America GDP Per Capita, By Country, 2016-2021, $
  • Table 205:  North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 206:  North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 207: North America Healthcare Services Market Size, By Country, 2016-2026, $ Billion
  • Table 208: North America Ophthalmology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 209: North America Ophthalmology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 210: North America Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 211: North America Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 212: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 213: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 214: North America Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 215: North America Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 216: North America Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)

List Of Figures

    Figure 1: Global Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 2: Global Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 3: Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 4: Global Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Figure 5: Global Ophthalmology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Figure 6: Global Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 7: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 8: Global Ophthalmology Drugs Market, Segmentation By Type Of Prescription, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 9: Global Ophthalmology Drugs Market, Segmentation By Drug Variation, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 10: Asia-Pacific Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 11: Asia-Pacific Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 12: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 13: Asia- Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 14: Asia-Pacific Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 15: Asia-Pacific Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 16: Asia-Pacific Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 17: Australia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 18: Australia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 19: Australia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 20: Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 21: China Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 22: China Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 23: China Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 24: China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 25: Hong Kong Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 26: Hong Kong Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 27: India Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 28: India Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 29: India Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 30: India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 31: Indonesia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 32: Indonesia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 33: Indonesia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 34: Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 35: Japan Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 36: Japan Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 37: Japan Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 38: Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 39: Malaysia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 40: Malaysia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 41: New Zealand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 42: New Zealand Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 43: Philippines Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 44: Philippines Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 45: Singapore Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 46: Singapore Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 47: South Korea Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 48: South Korea Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 49: South Korea Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 50: South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 51: Thailand Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 52: Thailand Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 53: Vietnam Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 54: Vietnam Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 55: Western Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 56: Western Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 57: Western Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 58: Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 59: Western Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 60: Western Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 61: Western Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 62: Austria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 63: Austria Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 64: Belgium Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 65: Belgium Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 66: Denmark Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 67: Denmark Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 68: Finland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 69: Finland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 70: France Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 71: France Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 72: France Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 73: France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 74: Germany Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 75: Germany Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 76: Germany Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 77: Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 78: Ireland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 79: Ireland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 80: Italy Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 81: Italy Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 82: Italy Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 83: Italy Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 84: Netherlands Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 85: Netherlands Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 86: Norway Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 87: Norway Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 88: Portugal Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 89: Portugal Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 90: Spain Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 91: Spain Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 92: Spain Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 93: Spain Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 94: Sweden Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 95: Sweden Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 96: Switzerland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 97: Switzerland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 98: UK Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 99: UK Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 100: UK Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 101: UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 102: Eastern Europe Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 103: Eastern Europe Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 104: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 105: Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 106: Eastern Europe Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 107: Eastern Europe Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 108: Eastern Europe Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 109: Czech Republic Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 110: Czech Republic Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 111: Poland Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 112: Poland Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 113: Romania Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 114: Romania Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 115: Russia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 116: Russia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 117: Russia Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 118: Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 119: North America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 120: North America Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 121: North America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 122: North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 123: North America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 124: North America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 125: North America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 126: Canada Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 127: Canada Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 128: Mexico Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 129: Mexico Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 130: USA Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 131: USA Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 132: USA Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 133: USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 134: South America Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 135: South America Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 136: South America Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 137: South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 138: South America Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 139: South America Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 140: South America Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 141: Argentina Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 142: Argentina Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 143: Chile Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 144: Chile Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 145: Colombia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 146: Colombia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 147: Brazil Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 148: Brazil Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 149: Brazil Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 150: Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 151: Peru Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 152: Peru Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 153: Venezuela Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 154: Venezuela Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 155: Middle East Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 156: Middle East Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 157: Middle East Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 158: Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 159: Middle East Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 160: Middle East Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 161: Middle East Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 162: Israel Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 163: Israel Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 164: Saudi Arabia Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 165: Saudi Arabia Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 166: Turkey Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 167: Turkey Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 168: UAE Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 169: UAE Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 170: Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 171: Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 172: Africa Ophthalmology Drugs Market, Segmentation By Type Of Drug, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 173: Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 174: Africa Ophthalmology Drugs Market, 2019, By Country, Value ($ Million)
  • Figure 175: Africa Ophthalmology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 176: Africa Ophthalmology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 177: Egypt Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 178: Egypt Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 179: Nigeria Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 180: Nigeria Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 181: South Africa Ophthalmology Drugs Market, Historic, 2015 – 2019, $ Million
  • Figure 182: South Africa Ophthalmology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 183: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Figure 184: Allergan Plc.– Financial Performance, 2015 - 2019, $ Billion
  • Figure 185: Santen Pharmaceutical Co Ltd.– Financial Performance, 2014-2018, $ Billion
  • Figure 186: Global Pharmaceutical Drugs Market, 2019, Split By Segment
  • Figure 187: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Segment
  • Figure 188: Global Pharmaceutical Drugs Market, 2019, Split By Region
  • Figure 189: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the ophthalmology drugs market?

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies request a sample here

How will the ophthalmology drugs market drivers and restraints affect ophthalmology drugs market dynamics? What forces will shape the ophthalmology drugs industry going forward?

The ophthalmology drugs market growth is aided by rising number of people going for laser eye surgeries. However, some ophthalmology drugs market restraints include regulatory changes request a sample here

What is the forecast market size of the ophthalmology drugs market?

The ophthalmology drugs market forecast is expected to reach $32.64 billion in 2025 at a compound annual growth rate of 8%. request a sample here

How is the ophthalmology drugs market segmented?

The global ophthalmology drugs market is segmented -
1) By Type: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
request a sample here

Which region has largest share, and what is the market size and growth by geography according to the ophthalmology drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global ophthalmology drugs market?

Top competitors in the ophthalmology drugs market are Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG. request a sample here.

What are the key trends in the global ophthalmology drugs market?

Major trends influencing the ophthalmology drugs market include developing ophthalmic drugs with anti-inflammatory agents to ease patient treatment for dry eye syndrome request a sample here.

What are the major opportunities in the ophthalmology drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global ophthalmology drugs market, request a sample here.

How does the ophthalmology drugs market relate to the overall economy and other similar markets?